Endostatin is a cancer drug discovered in the '60s by Dr. Judah Folkman. He tried to commercialize it but the high costs of making it prevented his company, EntreMed, from making a success of it. Now, almost forty years later comes Dr. Luo Yongzhang, an American-educated researcher. He has apparently developed a version of endostatin that can be made at much less cost and is in talks with several US druge manufacturers to begin trials here.
I know that Dr. Hwang, the Korean stem cell researcher, has tarnished the reputation of Oriental researchers, but there is a strong possibility that Dr. Luo's work will be tested and pass the tests here.
The point of this post being that here is another example of the rise of China in the scientific world.
No comments:
Post a Comment